PNC Financial Services Group Inc. increased its position in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 2.2% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,134 shares of the business services provider’s stock after purchasing an additional 239 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Exponent were worth $1,284,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also added to or reduced their stakes in EXPO. Quadrature Capital Ltd boosted its holdings in shares of Exponent by 18.6% during the 1st quarter. Quadrature Capital Ltd now owns 4,562 shares of the business services provider’s stock valued at $377,000 after acquiring an additional 715 shares during the last quarter. Comerica Bank boosted its stake in shares of Exponent by 8.7% during the 1st quarter. Comerica Bank now owns 231,131 shares of the business services provider’s stock worth $19,112,000 after purchasing an additional 18,429 shares during the period. LRI Investments LLC bought a new position in Exponent in the 1st quarter valued at $123,000. GAMMA Investing LLC increased its position in shares of Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after acquiring an additional 153 shares during the period. Finally, OLD National Bancorp IN bought a new stake in shares of Exponent in the 2nd quarter valued at about $338,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.
Exponent Stock Performance
EXPO stock opened at $98.61 on Thursday. The firm has a market cap of $5.01 billion, a price-to-earnings ratio of 47.64 and a beta of 0.69. Exponent, Inc. has a one year low of $68.70 and a one year high of $115.75. The firm has a 50-day simple moving average of $105.98 and a two-hundred day simple moving average of $102.25.
Exponent Announces Dividend
Insider Activity
In related news, Director Paul R. Johnston sold 14,000 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the completion of the sale, the director now owns 80,742 shares of the company’s stock, valued at approximately $8,445,613.20. This represents a 14.78 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $96.32, for a total transaction of $100,076.48. Following the sale, the director now directly owns 5,871 shares in the company, valued at approximately $565,494.72. The trade was a 15.04 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,339 shares of company stock valued at $3,103,065 in the last ninety days. Insiders own 2.10% of the company’s stock.
Exponent Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories
- Five stocks we like better than Exponent
- Investing in Travel Stocks Benefits
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- About the Markup Calculator
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Nasdaq? Complete Overview with History
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.